Macugen (Bausch & Lomb Incorporated)
Welcome to the PulseAid listing for the Macugen drug offered from Bausch & Lomb Incorporated. This Oligonucleotides [Chemical/Ingredient],Aptamers, Nucleotide [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Bausch & Lomb Incorporated |
NON-PROPRIETARY NAME: | pegaptanib sodium |
SUBSTANCE NAME: | PEGAPTANIB SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Oligonucleotides [Chemical/Ingredient],Aptamers, Nucleotide [Chemical/Ingredient] |
ROUTE: | INTRAVITREAL |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2004-12-17 |
END MARKETING DATE: | 0000-00-00 |
Macugen HUMAN PRESCRIPTION DRUG Details:
Item Description | Macugen from Bausch & Lomb Incorporated |
LABELER NAME: | Bausch & Lomb Incorporated |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3.47(mg/mL) |
START MARKETING DATE: | 2004-12-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68782-001_48b1952b-3ef6-4437-8592-5f4f4543e370 |
PRODUCT NDC: | 68782-001 |
APPLICATION NUMBER: | NDA021756 |
Other PEGAPTANIB SODIUM Pharmaceutical Manufacturers / Labelers: